vs

Side-by-side financial comparison of Nebius Group N.V. (NBIS) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

RxSight, Inc. is the larger business by last-quarter revenue ($32.6M vs $32.1M, roughly 1.0× Nebius Group N.V.). RxSight, Inc. produced more free cash flow last quarter ($-2.3M vs $-586.8M).

Nebius Group N.V., headquartered in Amsterdam, is a technology company that provides artificial intelligence infrastructure. The company also owns Avride and TripleTen, as well as stakes in Toloka and Clickhouse. It is headquartered in Amsterdam with offices in Israel and the United States.

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

NBIS vs RXST — Head-to-Head

Bigger by revenue
RXST
RXST
1.0× larger
RXST
$32.6M
$32.1M
NBIS
More free cash flow
RXST
RXST
$584.5M more FCF
RXST
$-2.3M
$-586.8M
NBIS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
NBIS
NBIS
RXST
RXST
Revenue
$32.1M
$32.6M
Net Profit
$-9.2M
Gross Margin
77.5%
Operating Margin
-251.1%
-34.8%
Net Margin
-28.1%
Revenue YoY
-18.9%
Net Profit YoY
-54.1%
EPS (diluted)
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NBIS
NBIS
RXST
RXST
Q4 25
$32.6M
Q3 25
$32.1M
$30.3M
Q2 25
$24.2M
$33.6M
Q1 25
$37.9M
Q4 24
$40.2M
Q3 24
$79.6M
$35.3M
Q2 24
$36.3M
$34.9M
Q1 24
$29.5M
Net Profit
NBIS
NBIS
RXST
RXST
Q4 25
$-9.2M
Q3 25
$-9.8M
Q2 25
$-185.4M
$-11.8M
Q1 25
$-8.2M
Q4 24
$-5.9M
Q3 24
$-258.2M
$-6.3M
Q2 24
$-118.3M
$-6.1M
Q1 24
$-9.1M
Gross Margin
NBIS
NBIS
RXST
RXST
Q4 25
77.5%
Q3 25
79.9%
Q2 25
74.9%
Q1 25
74.8%
Q4 24
71.6%
Q3 24
71.4%
Q2 24
69.5%
Q1 24
70.1%
Operating Margin
NBIS
NBIS
RXST
RXST
Q4 25
-34.8%
Q3 25
-251.1%
-40.1%
Q2 25
-754.1%
-41.6%
Q1 25
-28.2%
Q4 24
-21.5%
Q3 24
-366.1%
-26.1%
Q2 24
-563.1%
-23.9%
Q1 24
-36.2%
Net Margin
NBIS
NBIS
RXST
RXST
Q4 25
-28.1%
Q3 25
-32.4%
Q2 25
-766.1%
-35.0%
Q1 25
-21.6%
Q4 24
-14.8%
Q3 24
-324.4%
-17.9%
Q2 24
-325.9%
-17.4%
Q1 24
-30.8%
EPS (diluted)
NBIS
NBIS
RXST
RXST
Q4 25
$-0.22
Q3 25
$-0.24
Q2 25
$-0.29
Q1 25
$-0.20
Q4 24
$-0.14
Q3 24
$-0.16
Q2 24
$-0.16
Q1 24
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NBIS
NBIS
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$4.8B
$228.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.8B
$275.7M
Total Assets
$10.1B
$311.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NBIS
NBIS
RXST
RXST
Q4 25
$228.1M
Q3 25
$4.8B
$227.5M
Q2 25
$1.7B
$227.5M
Q1 25
$229.3M
Q4 24
$237.2M
Q3 24
$2.3B
$237.1M
Q2 24
$2.3B
$233.3M
Q1 24
$125.4M
Stockholders' Equity
NBIS
NBIS
RXST
RXST
Q4 25
$275.7M
Q3 25
$4.8B
$276.0M
Q2 25
$3.8B
$278.0M
Q1 25
$279.3M
Q4 24
$281.2M
Q3 24
$2.9B
$277.3M
Q2 24
$4.3B
$275.2M
Q1 24
$163.9M
Total Assets
NBIS
NBIS
RXST
RXST
Q4 25
$311.8M
Q3 25
$10.1B
$308.5M
Q2 25
$5.1B
$309.0M
Q1 25
$313.0M
Q4 24
$318.6M
Q3 24
$3.0B
$310.5M
Q2 24
$4.4B
$305.5M
Q1 24
$183.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NBIS
NBIS
RXST
RXST
Operating Cash FlowLast quarter
$-196.8M
$-1.1M
Free Cash FlowOCF − Capex
$-586.8M
$-2.3M
FCF MarginFCF / Revenue
-1828.0%
-6.9%
Capex IntensityCapex / Revenue
1215.0%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NBIS
NBIS
RXST
RXST
Q4 25
$-1.1M
Q3 25
$-196.8M
$-1.2M
Q2 25
$-162.0M
$-4.4M
Q1 25
$-8.8M
Q4 24
$-4.3M
Q3 24
$650.0K
Q2 24
$-4.0M
Q1 24
$-9.3M
Free Cash Flow
NBIS
NBIS
RXST
RXST
Q4 25
$-2.3M
Q3 25
$-586.8M
$-1.8M
Q2 25
$-379.9M
$-5.9M
Q1 25
$-9.4M
Q4 24
$-5.1M
Q3 24
$-453.0K
Q2 24
$-5.5M
Q1 24
$-11.3M
FCF Margin
NBIS
NBIS
RXST
RXST
Q4 25
-6.9%
Q3 25
-1828.0%
-5.8%
Q2 25
-1569.8%
-17.6%
Q1 25
-24.8%
Q4 24
-12.7%
Q3 24
-1.3%
Q2 24
-15.9%
Q1 24
-38.2%
Capex Intensity
NBIS
NBIS
RXST
RXST
Q4 25
3.5%
Q3 25
1215.0%
1.9%
Q2 25
900.4%
4.6%
Q1 25
1.5%
Q4 24
2.1%
Q3 24
3.1%
Q2 24
4.4%
Q1 24
6.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NBIS
NBIS

Nebius$27.1M84%
TripleTen$6.3M20%
Avride$100.0K0%

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons